Reporter Oct 25 2019
Oct. 24, 2019—Thomas Wang, MD, director of Cardiovascular Medicine at VUMC, has been appointed chair of Internal Medicine at the University of Texas Southwestern Medical Center in Dallas, effective February 2020.
Oct. 24, 2019—Brian Rini, MD, an internationally recognized leader in genitourinary oncology, kidney cancer, and clinical drug development, is joining Vanderbilt-Ingram Cancer Center as the inaugural chief of Clinical Trials.
Oct. 24, 2019—Genotyping can improve outcomes in patients who require anti-platelet therapy following stent placement to open narrowed or blocked coronary arteries and prevent a heart attack.
Oct. 24, 2019—Vanderbilt's Alex Diamond, DO, MPH, has been named to the National Federation of State High School Associations (NFHS) Sports Medicine Advisory Committee.
Oct. 24, 2019—On Oct. 30, Value-Based Care University is hosting its first educational event for frontline clinicians, and the free event can be attended either in person or through a live webinar.
Oct. 24, 2019—Renowned integrative health expert Helene Langevin, MD, CM, is set to be the inaugural speaker of a new lecture series hosted by the Osher Center for Integrative Medicine at Vanderbilt.
Oct. 24, 2019—Some of the nation’s leading genitourinary cancer physicians will speak about the latest advances in care at an OncLive State of the Science Summit held in collaboration with Vanderbilt-Ingram Cancer Center.
Oct. 24, 2019—Eskind Family Biomedical Library and Learning Center is sponsoring an exhibit from April 8 to May 8, 2020, titled, “Telling our stories: graphic medicine and the intersection of art and health care.”
Oct. 24, 2019—On Wednesday, Nov. 4, VUMC's Office for Diversity Affairs will present the third annual “Hidden VUMC Figures” event — a tribute to employees who have made significant long-term contributions to the Medical Center, often behind the scenes.
Oct. 24, 2019—David Page, MD, former professor of Pathology and Preventive Medicine at Vanderbilt University School of Medicine, whose work revolutionized the assessment of breast cancer risk, died in Nashville on Thursday, Oct. 17. He was 78.